Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat

Eur Neuropsychopharmacol. 2007 Jan;17(1):64-9. doi: 10.1016/j.euroneuro.2006.03.003. Epub 2006 Apr 19.

Abstract

The effect of intracerebroventricular infusion of galanin and/or the galanin antagonist M35 was studied in the forced swim test. Animals were pre-exposed to water for 15 min 24 h prior to test. Immobility and climbing were assessed during the second, 5 min exposure to water. Rats receiving a single infusion of galanin (3 nmol) displayed a significant increase of immobility. This effect was blocked by co-administration of M35 (1 nmol). M35 alone (1 nmol) produced a significant decrease of immobility. The results further support the hypothesis that galanin may play a role in mood disorders, and that galanin antagonists may represent new candidates for antidepressant treatment.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Behavior, Animal
  • Bradykinin / administration & dosage
  • Bradykinin / analogs & derivatives*
  • Depression / drug therapy*
  • Depression / physiopathology*
  • Disease Models, Animal
  • Drug Combinations
  • Galanin / administration & dosage*
  • Galanin / antagonists & inhibitors
  • Immobility Response, Tonic / drug effects
  • Injections, Intraventricular / methods
  • Male
  • Peptide Fragments / administration & dosage*
  • Rats
  • Rats, Sprague-Dawley
  • Swimming

Substances

  • Drug Combinations
  • Peptide Fragments
  • galanin-(1-13)-bradykinin-(2-9)-amide
  • Galanin
  • Bradykinin